SCHEMBL24309866

SCHEMBL24309866

Cc1cc(C)c(Oc2cc(Oc3ccc(N4CCNCC4)cc3)nc(NSc3cnn(C)c3)n2)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 1/20 0.36
▸ LTA4H P09960 4/20 0.35
▸ ADRB1 P08588 3/20 0.34
▸ HTR3E A5X5Y0 1/20 0.34
▸ HTR3B O95264 1/20 0.34
▸ HTR3A P46098 1/20 0.34
▸ HTR3D Q70Z44 1/20 0.34
▸ HTR3C Q8WXA8 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ ACVR1 Q04771 3/20 0.34
▸ HTR1A P08908 2/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR7 P34969 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ TGFBR1 P36897 3/20 0.33
▸ BMPR1B O00238 2/20 0.33
▸ BMPR1A P36894 2/20 0.33
▸ ACVRL1 P37023 2/20 0.33
▸ PDGFRB P09619 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309516 0.90 FLT3 (0.35) FLT3LTA4HADRB1HTR3EHTR3B
SCHEMBL24309743 0.86 LTA4H (0.41) FLT3LTA4HADRB1HTR3EHTR3B
SCHEMBL24310587 0.85 FLT3 (0.37) FLT3LTA4HADRB1HTR3EHTR3B
SCHEMBL24309676 0.84 FLT3 (0.38) FLT3LTA4HACVR1HTR1AHTR7
SCHEMBL26807728 0.82 FLT3 (0.37) FLT3LTA4HACVR1HTR1ADRD2
SCHEMBL24309698 0.82 CDK4 (0.37) FLT3LTA4HADRB1HTR3EHTR3B
SCHEMBL24310026 0.80 ACVR1 (0.32) LTA4HADRB1HTR3EHTR3BHTR3A
SCHEMBL24309667 0.80 FLT3 (0.36) FLT3LTA4HACVR1HTR7TGFBR1
SCHEMBL24309611 0.79 CDK1 (0.34) FLT3LTA4HADRB1HTR3EHTR3B
SCHEMBL24309732 0.79 LTA4H (0.35) FLT3LTA4HACVR1TGFBR1MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback